Understanding and meeting the needs of those using growth hormone injection devices.

Authors:
Dumas H; Panayiotopoulos P; Parker D; Pongpairochana V.

Journal:
BMC Endocr Disord

Publication Year: 2006

DOI:
10.1186/1472-6823-6-5

PMCID:
PMC1618831

PMID:
17034628

View on PubMed View on PMC View Publisher
Journal Information

Full Title: BMC Endocr Disord

Abbreviation: BMC Endocr Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel.
Lertsakulbunlue S; Sangkool T; Bhuriveth V and 4 more (2024) - Transparency Score: 3/6
Clinical application of combination [<sup>11</sup>C]C-methionine and [<sup>13</sup>N]N-ammonia PET/…
Wang Z; Feng Z; Zhu D and 4 more (2024) - Transparency Score: 3/6
Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.
Fang Y; Mei W; Wang C and 8 more (2024) - Transparency Score: 3/6
Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer.
Zhuang Y; Cai Q; Hu X and 1 more (2024) - Transparency Score: 3/6
Fear of hypoglycemia and illness perception in type II diabetes patients.
Fariba A; Amerzadeh M; Banazadeh M and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests HD, PP and VP are employees of Serono International SA. DP is an employee of Fast Forward Research Ltd who conducted the survey for Serono International SA, Geneva, Switzerland."

Evidence found in paper:

"AcknowledgementsJanet Davies of Fast Forward Research Ltd provided valuable help with data acquisition, analysis and interpretation. Writing assistance was provided by Imogen Horsey. Both the survey and preparation of the manuscript were funded by Serono International SA, Geneva, Switzerland."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025